Method for purifying pseudomonas aeruginosa vaccine recombinant protein Vac 9

A Pseudomonas aeruginosa purification method technology, applied in the field of biopharmaceuticals, can solve the problems of recombinant protein Vac9 purification methods and reports that have not yet been seen, and achieve good immune protection, good repeatability, and high humoral immune response.

Inactive Publication Date: 2016-06-01
ARMY MEDICAL UNIV
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no report on the purific

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for purifying pseudomonas aeruginosa vaccine recombinant protein Vac 9
  • Method for purifying pseudomonas aeruginosa vaccine recombinant protein Vac 9
  • Method for purifying pseudomonas aeruginosa vaccine recombinant protein Vac 9

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0064] Example 1: Cloning of OprL gene and construction of recombinant plasmid pGEX-6P-2-OprL

[0065] 1. First, according to the full-length gene sequence of the OprL protein of Pseudomonas aeruginosa PA01, use bioinformatics software to conduct structural analysis to determine the OprL target gene fragment that needs to be amplified.

[0066] 2. According to the analysis results, the PCR method was used to amplify the OprL target gene fragment from the PA01 genome. The amplification steps are as follows:

[0067] 1) Design PCR primers as follows, respectively SEQIDNO: 3-4 (the base sequence of the restriction site is underlined)

[0068] Seq ID

[0069] 2) Pseudomonas aeruginosa strain PA01 taken out of the freezer at -80°C was spread on LB solid medium, cultured overnight at 37°C, and then a single colony was picked and inoculated in LB liquid medium for 8 hours , Refer to the bacterial genome extraction kit to extract the PA01 genome.

[0070] 3) PCR amplification of OprL gene f...

Example Embodiment

[0098] Example 2: Induced expression of recombinant fusion protein Vac9 in a prokaryotic expression system-Escherichia coli and identification of the expression form

[0099] 1. Induced expression of recombinant protein Vac9

[0100] Take 100μL of the pGEX-6P-2-OprL / XL-1blue cultured overnight and add it to 10mL Amp+ resistant LB medium, culture overnight at 180rpm at 37℃, respectively take 400μL of the overnight cultured bacterial solution and add 20mL Amp+ resistant LB medium (The remaining bacterial solution is stored in a refrigerator at 4°C for later use), cultured at 37°C for 2 to 3 hours, at a rotation speed of 200 rpm, and after the second activation to an OD600 of 0.8-1.0, add 4 μL of IPTG to make the final concentration 200 μM, and then place it on a shaker Induced expression at 30℃ for 3h.

[0101] 2) Take out the bacterial solution after induced expression, centrifuge at 12000rpm for 5min, discard the supernatant, add 1mL lysisbuffer (20mMPB, pH7.2, 250mMNacl) and mix we...

Example Embodiment

[0108] Example 3: Preparation of recombinant protein Vac9 antigen

[0109] 1. Amplify the culture to obtain protein

[0110] Take 400μL of pGEX-6P-2-OprL / XL-1blue bacterial solution stored in the refrigerator at 4℃ for later use and add it to 20mL of Amp-resistant LB medium for one activation. After incubating at 200rpm at 37℃ for 5-6 hours, take 8mL once The activated bacteria solution was added to 400 mL of Amp-resistant LB medium for secondary activation. After culturing at 37°C for 3 to 4 hours until the OD600 reached 1.0, add 80 μL of IPTG (final concentration of 200 μM) and place in a 16°C shaker overnight for induction. Afterwards, the cells were collected by centrifugation at 12000rpm for 15min, and 20mL of lysisbuffer (same as in Example 2) was added to resuspend the cells. The bacteria solution was subjected to ultrasonic lysis for 3min (200V). Company) Gel beads (beads) binding treatment; then SDS-PAGE gel electrophoresis.

[0111] 2. Use restriction digestion method to ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for purifying pseudomonas aeruginosa (PA) recombinant subunit genetic engineering protein vaccine Vac 9. The Vac 9 protein is obtained in the mode that pseudomonas aeruginosa cell outer membrane protein is recombined and confused, and escherichia coli genetically engineered bacterium expression is conducted. Technologies including high pressure bacterium breaking, GST affinity chromatography, Prescission Protease (PP enzyme) restriction enzyme digestion, Phenyl HP chromatography, G25 chromatography, Q HP endotoxin removal and the like are conducted on genetic engineering bacteria, and the high-purity pseudomonas aeruginosa (PA) recombinant subunit genetic engineering protein vaccine Vac 9 is obtained. The method is simple and fast in purifying process, easy to amplify and good in repeatability, the obtained target protein is high in purity, the production requirements of genetic engineering vaccines can be met, and it is proved by animal tests that a mechanism can be effectively stimulated to generate high humoral immune response and a good immune protective effect.

Description

technical field [0001] The invention belongs to the field of biopharmaceuticals, in particular to a method for purifying the recombinant protein Vac9 (OprL) of Pseudomonas aeruginosa (PA) vaccine. Background technique [0002] Pseudomonas aeruginosa (Pseudomonas aeruginosa, PA), commonly known as Pseudomonas aeruginosa, belongs to the genus Pseudomonas in non-fermenting bacteria. It is ubiquitous and is one of the most common opportunistic pathogens in clinical practice. Due to the high clinical infection rate of PA and the rising rate of drug resistance, it is imminent to find new "non-antibiotic therapy". From the perspective of immunology, it is the most ideal choice to develop a safe and effective vaccine. [0003] OprL is a peptidoglycan associated lipoprotein of Pseudomonas aeruginosa, which is located in the outer membrane of Pseudomonas aeruginosa and plays an important role in the physiological and pathological processes of bacteria. OprL protein is highly conserv...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K14/21C12N15/31C07K1/22C07K1/16
CPCC07K14/21
Inventor 敬海明顾江邹全明章金勇孙红武付强牟道华张玉东徐丽敏
Owner ARMY MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products